📰 Todd Binder News
Page 2 - Todd Binder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Todd Binder. Real-time updates on events, politics, business and more.
March 29, 2022
NEUVOGEN Appoints Biotechnology Veteran, Mark Backer, PhD as Head of Technical Operations - read this article along with other careers information, tips and advice on BioSpace
March 28, 2022
/PRNewswire/ -- NEUVOGEN, an immunoncology company, announced today that Mark Backer, PhD has joined the company as Head of Technical Operations, and will be...
December 21, 2021
/PRNewswire/ -- NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee...
December 21, 2021
/PRNewswire/ -- NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee...
January 28, 2021
ImaginAb and NEUVOGEN Announce Licensing Agreement for CD8 ImmunoPET Technology News provided by Share this article Share this article LOS ANGELES and SAN DIEGO, Jan. 28, 2021 /PRNewswire/ -- ImaginAb Inc, a leading global provider of immuno-oncology imaging agents and NEUVOGEN, an immuno-oncology company developing next generation therapeutic whole cell cancer vaccines, announced they have signed a multi-year non-exclusive licensing agreement. Under the terms of the agreement, ImaginAb ...
January 20, 2021
/PRNewswire/ -- NEUVOGEN today announced that Todd Binder, Chief Executive Officer of NEUVOGEN, will participate in the B. Riley Virtual Oncology Investor...